Suitability of a liquid chromatography assay of neomycin sulfate to replace the microbiological assay for neomycin in USP Monographs

Journal of Pharmaceutical and Biomedical Analysis

Volumn 51, Issue 1, 2010, Pages 96-102

  Hanko, Valoran P ^a   Rohrer, Jeffrey S ^a  

^a DIONEX CORPORATION   (United States)

Author keywords

Aminoglycoside; Amperometric; Amperometry; Anion exchange; Antibiotic; Chromatography; Cortisporin; Cream; Electrochemical; Gel; HPAE IPAD; HPAE PAD; Irrigant; Neomycin sulfate; Neosporin; Ointment; Ophthalmic; Pharmaceutical; Suspension

Indexed keywords

CORTISPORIN; NEO RX; NEOMYCIN; ORIGINAL NEOSPORIN; UNCLASSIFIED DRUG;

AMPEROMETRY; ARTICLE; BIOASSAY; CONCENTRATION (PARAMETERS); DRUG FORMULATION; DRUG SCREENING; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; DOSAGE FORMS; NEOMYCIN; PHARMACOPOEIAS AS TOPIC; REPRODUCIBILITY OF RESULTS; TIME FACTORS; UNITED STATES;

EID: 70349322389     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.08.011     Document Type: Article

References (22)

1. Waksman S.A. Neomycin. Nature, Formation, Isolation, and Practical Application (1953), Rutgers University Press, New Brunswick, NJ
2. Waksman S.A., and Lechevalier H.A. Guide to the Classification and Identification of the Actinomycetes and their Antibiotics (1953), The Williams & Wilkins Co., Baltimore, MD
3. Waksman S.A. Neomycin. Its Nature and Practical Application (1958), The Williams & Wilkins Co., Baltimore, MD
4. Rinehart K.L. The neomycins and related antibiotics. Chemistry of Microbial Products E.R. Squibb Lectures on Chemistry of Microbial Products (1964), Institute of Microbiology, John Wiley & Sons, Inc., New York, NY
5. United States Pharmacopeia, The National Formulary, Official Monographs, Neomycin Sulfate, USP 31, NF 26, 2008, p. 2770.
6. United States Pharmacopeia, The National Formulary, Official Monographs, <81> Antibiotics-Microbial Assays, USP 31, NF 26, 2008, pp. 91-98.
7. United States Pharmacopeia, The National Formulary, Official Monographs, <111> Design and Analysis of Biological Assays. Potencies Interpolated from a Standard Curve, USP 31, NF 26, 2008, pp. 108-120.
8. European Pharmacopia (EP). Neomycin Sulphate, Section 0197. Fourth Edition (2004), The Council of Europe, 67075 Strasbourg Cedex, France. http://www.pheur.org/ http://www.pheur.org
9. European Pharmacopia (EP). Framycetin Sulphate, Section 0180. Fourth Edition (2004), The Council of Europe, 67075 Strasbourg Cedex, France. http://www.pheur.org/ http://www.pheur.org
10. Szunyog J., Adams E., Roets E., and Hoogmartens J. J. Pharm. Biomed. Anal. 23 (2000) 891-896
11. Polta J.A., Johnson D.C., and Merkel K.E. J. Chromatogr. 324 (1985) 407-414
12. Adams E., Schepers R., Roets E., and Hoogmartens J. J. Chromatogr. A 741 (1996) 233-240
13. Statler J.A. J. Chromatogr. 92 (1990) 244-246
14. Dionex Corporation, Determination of Tobramycin and Impurities Using HPAE-PAD, Application Note 61, Sunnyvale, CA, Literature product no. 1626, July 2004.
15. Dionex Corporation, Determination of Neomycin B and Impurities Using HPAE-PAD, Application Note 66, Sunnyvale, CA, Literature product no. 1828, July 2006.
16. Hanko V.P., and Rohrer J.S. J. Pharm. Biomed. Anal. 40 (2006) 1006-1012
17. Hanko V.P., and Rohrer J.S. J. Pharm. Biomed. Anal. 43 (2007) 131-141
18. Hanko V.P., Rohrer J.S., Liu H.H., Zheng C., Zhang S., Liu X., and Tang X. J. Pharm. Biomed. Anal. 47 (2008) 828-833
19. Cao Y., Cheng J., Mou S., and Jandik P. Pharmacopeial Forum 30 (2004) 1501-1507
20. United States Pharmacopeia, The National Formulary, Official Monographs, Streptomycin Sulfate, USP 31, NF 26, 2008, p. 3275.
21. United States Pharmacopeia, The National Formulary, Official Monographs, <1225> Validation of Compendial Procedures, USP 31, NF 26, 2008, pp. 683-687.
22. United States Pharmacopeia, The National Formulary, Official Monographs, Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ointment, USP 31, NF 26, 2008, p. 2782.